Granite Point Capital Management, L.P. Aclaris Therapeutics, Inc. Transaction History
Granite Point Capital Management, L.P.
- $0
- Q3 2023
Shares
2 transactions
Others Institutions Holding ACRS
# of Institutions
102Shares Held
53.5MCall Options Held
51KPut Options Held
31.6K-
Bml Capital Management, LLC Zionsville, IN9.4MShares$12.4 Million7.8% of portfolio
-
Black Rock Inc. New York, NY5.2MShares$6.87 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.93MShares$6.51 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.28MShares$4.33 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.27MShares$4.32 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $88M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...